Particles

Patent metadata

Field	Value
Publication number	US-2016279282-A1
Application number	US-201615081648-A
Country	US
Kind code	A1
Filing date	Mar 25, 2016
Priority date	Mar 26, 2015
Publication date	Sep 29, 2016
Grant date	—

Abstract

Embolic particles are described comprising a treated polymer particle. The particles are reaction products of a prepolymer solution including at least one polyether macromer and an appropriate monomer. The treated polymer particles can have a first diameter that is smaller than a second diameter, wherein the second diameter is achieved when the treated polymer particle is subjected to a physiological condition. Methods of making and using these polymer particles are also described.

First claim

We claim:

1 . An embolic composition comprising:
embolic particles including acidic groups that are treated with a low pH solution to form treated embolic particles, wherein the treated embolic particles have a first diameter and a second diameter, and wherein the second diameter is larger than the first diameter when the treated polymer particle is subjected to a physiological condition.

2 . The embolic composition of claim 1 , wherein the first diameter is between about 40 μm and about 1,200 μm.

3 . The embolic composition of claim 2 , wherein the first diameter is smaller than the diameter of a microcatheter.

4 . The embolic composition of claim 1 , wherein the second diameter is between about 80 μm and about 3,600 μm.

5 . The embolic composition of claim 4 , wherein the second diameter is larger than the diameter of the microcatheter.

6 . The embolic composition of claim 1 , wherein the embolic particles include a reaction product of a prepolymer solution including at least one macromer and at least one monomer including ionic groups.

7 . The embolic composition of claim 6 , wherein the monomer containing ionic groups is sodium acrylate.

8 . The embolic composition of claim 6 , wherein the at least one macromer is poly(ethylene glycol) diacrylamide, poly(ethylene glycol) diacrylate, poly(ethylene glycol) dimethacrylate, poly(ethylene glycol) dimethacrylamide, or a combination thereof.

9 . The embolic composition of claim 6 , wherein the prepolymer solution further includes a biodegradable crosslinker having a structure:

wherein each n is independently 1-20;

wherein d, e, f, and g are each independently 1-20; or

10 . The embolic composition of claim 1 , wherein the embolic particles further include a visualization agent having a structure:

11 . The embolic composition of claim 1 , wherein the physiological condition is physiological pH.

12 . A method of making polymer particles comprising:
treating polymer particles formed by reacting a prepolymer solution including at least one macromer, an acrylic monomer, and an initiator in non-solvent to form treated polymer particles; wherein the treated polymer particle has a first diameter and a second diameter, wherein the second diameter is larger than the first diameter when the treated polymer particle is subjected to a physiological condition.

13 . The method of claim 12 , wherein the non-solvent is a mineral oil, hexane, or water.

14 . The method of claim 12 , wherein the initiator is ammonium persulfate, tetramethylethylene diamine, or a combination thereof.

15 . The method of claim 12 , wherein the first diameter is between about 40 μm and about 1,200 μm.

16 . The method of claim 15 , wherein the first diameter is smaller than the diameter of a microcatheter.

17 . The method of claim 12 , wherein the second diameter is between about 80 μm and about 3,600 μm.

18 . The method of claim 17 , wherein the second diameter is larger than the diameter of the microcatheter.

19 . The method of claim 12 , wherein the at least one macromer is poly(ethylene glycol) diacrylamide, poly(ethylene glycol) diacrylate, poly(ethylene glycol) dimethacrylate, poly(ethylene glycol) dimethacrylamide, or a combination thereof.

20 . The method of claim 12 , wherein the treating is acid treating and the monomer containing ionic groups is sodium acrylate or the treating is base treating and the monomer containing ionic groups includes amino groups.

Assignees

• Microvention Inc

Inventors

• Cruise Gregory M
• Plotkin Steve
• Wu Xinping

Classifications

• A61L24/001

  Use of materials characterised by their function or physical properties · CPC title

• A61L2430/36

  for embolization or occlusion, e.g. vaso-occlusive compositions or devices · CPC title

• C08F222/385

  Monomers containing two or more (meth)acrylamide groups, e.g. N,N'-methylenebisacrylamide · CPC title

• A61L24/06 Primary

  obtained by reactions only involving carbon-to-carbon unsaturated bonds {(A61L24/043, A61L24/046 take precedence)} · CPC title